Pavet et al., in 2010, reported that DR5-selective TRAIL-mimetic peptides (M1d) have vigorous tumoricidal activity against xenografted colon cancer cells (Pavet et al., 2010). This evidence concerns the gene TNFRSF10B and colonic neoplasm.